Logo image of ENFN

ENFUSION INC - CLASS A (ENFN) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:ENFN - US2928121043 - Common Stock

10.76 USD
-0.04 (-0.37%)
Last: 4/17/2025, 8:15:24 PM
10.76 USD
0 (0%)
After Hours: 4/17/2025, 8:15:24 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ENFN. ENFN was compared to 277 industry peers in the Software industry. ENFN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ENFN shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year ENFN was profitable.
  • ENFN had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: ENFN reported negative net income in multiple years.
  • Of the past 5 years ENFN 4 years had a positive operating cash flow.
ENFN Yearly Net Income VS EBIT VS OCF VS FCFENFN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

  • The Return On Assets of ENFN (1.97%) is better than 67.61% of its industry peers.
  • With a decent Return On Equity value of 3.86%, ENFN is doing good in the industry, outperforming 68.66% of the companies in the same industry.
  • ENFN has a Return On Invested Capital of 3.55%. This is in the better half of the industry: ENFN outperforms 73.24% of its industry peers.
Industry RankSector Rank
ROA 1.97%
ROE 3.86%
ROIC 3.55%
ROA(3y)0.28%
ROA(5y)-33.14%
ROE(3y)0.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ENFN Yearly ROA, ROE, ROICENFN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

  • ENFN has a Profit Margin of 1.40%. This is in the better half of the industry: ENFN outperforms 65.14% of its industry peers.
  • ENFN's Profit Margin has declined in the last couple of years.
  • ENFN's Operating Margin of 3.05% is fine compared to the rest of the industry. ENFN outperforms 68.66% of its industry peers.
  • ENFN's Operating Margin has declined in the last couple of years.
  • ENFN has a Gross Margin (67.82%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of ENFN has remained more or less at the same level.
Industry RankSector Rank
OM 3.05%
PM (TTM) 1.4%
GM 67.82%
OM growth 3YN/A
OM growth 5Y-33.55%
PM growth 3YN/A
PM growth 5Y-42.1%
GM growth 3Y-1.76%
GM growth 5Y-1.01%
ENFN Yearly Profit, Operating, Gross MarginsENFN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ENFN is destroying value.
  • Compared to 1 year ago, ENFN has more shares outstanding
  • ENFN has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for ENFN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ENFN Yearly Shares OutstandingENFN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ENFN Yearly Total Debt VS Total AssetsENFN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

  • An Altman-Z score of 12.41 indicates that ENFN is not in any danger for bankruptcy at the moment.
  • ENFN's Altman-Z score of 12.41 is amongst the best of the industry. ENFN outperforms 90.49% of its industry peers.
  • ENFN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.41
ROIC/WACC0.32
WACC11%
ENFN Yearly LT Debt VS Equity VS FCFENFN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

  • A Current Ratio of 3.42 indicates that ENFN has no problem at all paying its short term obligations.
  • ENFN has a better Current ratio (3.42) than 76.76% of its industry peers.
  • ENFN has a Quick Ratio of 3.42. This indicates that ENFN is financially healthy and has no problem in meeting its short term obligations.
  • ENFN has a better Quick ratio (3.42) than 76.76% of its industry peers.
Industry RankSector Rank
Current Ratio 3.42
Quick Ratio 3.42
ENFN Yearly Current Assets VS Current LiabilitesENFN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 35.71% over the past year.
  • Measured over the past years, ENFN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -22.78% on average per year.
  • ENFN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.51%.
  • The Revenue has been growing by 27.86% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)35.71%
EPS 3YN/A
EPS 5Y-22.78%
EPS Q2Q%-25%
Revenue 1Y (TTM)15.51%
Revenue growth 3Y21.76%
Revenue growth 5Y27.86%
Sales Q2Q%13.88%

3.2 Future

  • ENFN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.93% yearly.
  • Based on estimates for the next years, ENFN will show a quite strong growth in Revenue. The Revenue will grow by 15.45% on average per year.
EPS Next Y50.32%
EPS Next 2Y40.46%
EPS Next 3Y27.93%
EPS Next 5YN/A
Revenue Next Year16.39%
Revenue Next 2Y16.32%
Revenue Next 3Y15.45%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ENFN Yearly Revenue VS EstimatesENFN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
ENFN Yearly EPS VS EstimatesENFN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3

3

4. Valuation

4.1 Price/Earnings Ratio

  • ENFN is valuated quite expensively with a Price/Earnings ratio of 56.63.
  • The rest of the industry has a similar Price/Earnings ratio as ENFN.
  • When comparing the Price/Earnings ratio of ENFN to the average of the S&P500 Index (27.38), we can say ENFN is valued expensively.
  • With a Price/Forward Earnings ratio of 37.68, ENFN can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, ENFN is valued a bit cheaper than the industry average as 60.56% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.29, ENFN is valued quite expensively.
Industry RankSector Rank
PE 56.63
Fwd PE 37.68
ENFN Price Earnings VS Forward Price EarningsENFN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 61.97% of the companies in the same industry are more expensive than ENFN, based on the Enterprise Value to EBITDA ratio.
  • ENFN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 58.73
EV/EBITDA 74.97
ENFN Per share dataENFN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • ENFN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as ENFN's earnings are expected to grow with 27.93% in the coming years.
PEG (NY)1.13
PEG (5Y)N/A
EPS Next 2Y40.46%
EPS Next 3Y27.93%

0

5. Dividend

5.1 Amount

  • ENFN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ENFUSION INC - CLASS A

NYSE:ENFN (4/17/2025, 8:15:24 PM)

After market: 10.76 0 (0%)

10.76

-0.04 (-0.37%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-03
Earnings (Next)05-08
Inst Owners94.22%
Inst Owner Change0%
Ins Owners3.2%
Ins Owner Change0%
Market Cap1.40B
Revenue(TTM)201.61M
Net Income(TTM)2.82M
Analysts50.91
Price Target11.15 (3.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-26.01%
Min EPS beat(2)-52.94%
Max EPS beat(2)0.93%
EPS beat(4)2
Avg EPS beat(4)-0.65%
Min EPS beat(4)-52.94%
Max EPS beat(4)62.27%
EPS beat(8)2
Avg EPS beat(8)-9.58%
EPS beat(12)5
Avg EPS beat(12)0.54%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.8%
Min Revenue beat(2)-4.7%
Max Revenue beat(2)-2.9%
Revenue beat(4)0
Avg Revenue beat(4)-2.95%
Min Revenue beat(4)-4.7%
Max Revenue beat(4)-1.06%
Revenue beat(8)1
Avg Revenue beat(8)-2.79%
Revenue beat(12)3
Avg Revenue beat(12)-1.79%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.03%
PT rev (3m)7.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.71%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.51%
Revenue NY rev (1m)-0.6%
Revenue NY rev (3m)-0.73%
Valuation
Industry RankSector Rank
PE 56.63
Fwd PE 37.68
P/S 6.93
P/FCF 58.73
P/OCF 40.29
P/B 19.08
P/tB 19.08
EV/EBITDA 74.97
EPS(TTM)0.19
EY1.77%
EPS(NY)0.29
Fwd EY2.65%
FCF(TTM)0.18
FCFY1.7%
OCF(TTM)0.27
OCFY2.48%
SpS1.55
BVpS0.56
TBVpS0.56
PEG (NY)1.13
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.97%
ROE 3.86%
ROCE 5.31%
ROIC 3.55%
ROICexc 6.69%
ROICexgc 6.69%
OM 3.05%
PM (TTM) 1.4%
GM 67.82%
FCFM 11.8%
ROA(3y)0.28%
ROA(5y)-33.14%
ROE(3y)0.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-41.88%
ROICexc growth 3YN/A
ROICexc growth 5Y-41.88%
OM growth 3YN/A
OM growth 5Y-33.55%
PM growth 3YN/A
PM growth 5Y-42.1%
GM growth 3Y-1.76%
GM growth 5Y-1.01%
F-Score5
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 92.67%
Cap/Sales 5.4%
Interest Coverage 250
Cash Conversion 193.66%
Profit Quality 842.72%
Current Ratio 3.42
Quick Ratio 3.42
Altman-Z 12.41
F-Score5
WACC11%
ROIC/WACC0.32
Cap/Depr(3y)104.86%
Cap/Depr(5y)147.45%
Cap/Sales(3y)5.41%
Cap/Sales(5y)5.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.71%
EPS 3YN/A
EPS 5Y-22.78%
EPS Q2Q%-25%
EPS Next Y50.32%
EPS Next 2Y40.46%
EPS Next 3Y27.93%
EPS Next 5YN/A
Revenue 1Y (TTM)15.51%
Revenue growth 3Y21.76%
Revenue growth 5Y27.86%
Sales Q2Q%13.88%
Revenue Next Year16.39%
Revenue Next 2Y16.32%
Revenue Next 3Y15.45%
Revenue Next 5YN/A
EBIT growth 1Y-48.51%
EBIT growth 3YN/A
EBIT growth 5Y-15.03%
EBIT Next Year76.73%
EBIT Next 3Y40.41%
EBIT Next 5YN/A
FCF growth 1Y49.03%
FCF growth 3YN/A
FCF growth 5Y24.73%
OCF growth 1Y35.3%
OCF growth 3YN/A
OCF growth 5Y23.02%

ENFUSION INC - CLASS A / ENFN FAQ

What is the fundamental rating for ENFN stock?

ChartMill assigns a fundamental rating of 6 / 10 to ENFN.


Can you provide the valuation status for ENFUSION INC - CLASS A?

ChartMill assigns a valuation rating of 3 / 10 to ENFUSION INC - CLASS A (ENFN). This can be considered as Overvalued.


How profitable is ENFUSION INC - CLASS A (ENFN) stock?

ENFUSION INC - CLASS A (ENFN) has a profitability rating of 4 / 10.


What are the PE and PB ratios of ENFUSION INC - CLASS A (ENFN) stock?

The Price/Earnings (PE) ratio for ENFUSION INC - CLASS A (ENFN) is 56.63 and the Price/Book (PB) ratio is 19.08.


How financially healthy is ENFUSION INC - CLASS A?

The financial health rating of ENFUSION INC - CLASS A (ENFN) is 8 / 10.